About the Authors
- Romana Höftberger
-
Affiliations Service of Neurology, Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Institute of Neurology, Medical University of Vienna, Vienna, Austria
- Lidia Sabater
-
Affiliation Service of Neurology, Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Romain Marignier
-
Affiliation Team ONCOFLAM, Lyon Neuroscience Research Center INSERM U 1028/CNRS 5292, Lyon, France
- Fahmy Aboul-Enein
-
Affiliation Department of Neurology, SMZ-Ost Donauspital, Vienna, Austria
- Raphaël Bernard-Valnet
-
Affiliation Team ONCOFLAM, Lyon Neuroscience Research Center INSERM U 1028/CNRS 5292, Lyon, France
- Helmut Rauschka
-
Affiliation Department of Neurology, SMZ-Ost Donauspital, Vienna, Austria
- Anne Ruiz
-
Affiliation Team ONCOFLAM, Lyon Neuroscience Research Center INSERM U 1028/CNRS 5292, Lyon, France
- Yolanda Blanco
-
Affiliation Service of Neurology, Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Francesc Graus
-
Affiliation Service of Neurology, Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Josep Dalmau
-
Affiliations Institució Catalana de Recerca i Estudis Avançats (ICREA), IDIBAPS, Hospital Clínic, Barcelona, Spain, Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
- Albert Saiz
-
* E-mail: asaiz@clinic.ub.es
Affiliation Service of Neurology, Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Competing Interests
We have the following interests. Dr. Dalmau has a research grant from Euroimmun and receives royalties from Athena Diagnostics for a patent for the use of Ma2 as autoantibody test, and licensing fees from Euroimmun for a patent for the use of NMDAR as autoantibody test. The patents concerned are: Patent Ma2: US 6,387,639 and Patent NMDAR: US 7972796 B2. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: RH LS RM FA FG JD AS. Performed the experiments: RH LS RM FA. Analyzed the data: RH AS. Contributed reagents/materials/analysis tools: RH LS RM FA RB HR AR YB FG JD AS. Wrote the manuscript: RH FG JD AS. Statistics: YB.